Konstantinos Karatzas

Grundare på

Acesis Holdings Corp.

67 år

Consumer Services

Technology Services

Health Technology

Profil

Dr. Konstantinos Karatzas is a Chief Executive Officer & Director at Acesis Holdings Corp.
He is on the Board of Directors at Acesis Holdings Corp.
and Applied Biotech Intelligence.
Dr. Karatzas was previously employed as a Chief Executive Officer by Acesis, Inc. He received his undergraduate degree from National & Kapodistrian University of Athens, a graduate degree from McGill University and an MBA from McGill University.

Aktiva positioner av Konstantinos Karatzas

Företag	Position	Start
Acesis Holdings Corp. Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders	Grundare	2022-10-03
Applied Biotech Intelligence	Direktör/Styrelseledamot	2015-01-01

Alla aktiva positioner av Konstantinos Karatzas

Tidigare kända positioner av Konstantinos Karatzas

Företag	Position	Slut
Acesis, Inc. Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians	Verkställande Direktör	-

Se detaljerna i Konstantinos Karatzass erfarenhet

Konstantinos Karatzass utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Konstantinos Karatzass erfarenhet

Kopplade företag

Privata företag	5
Acesis, Inc. Acesis, Inc. Packaged SoftwareTechnology Services Develops software solutions that offers data capture forms for physicians	Technology Services
McGill University McGill University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National & Kapodistrian University of Athens National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acesis Holdings Corp. Acesis Holdings Corp. BiotechnologyHealth Technology Functions as an investment holding company whose subsidiaries developing platform of oral drug candidates for metabolic and endocrine disorders	Health Technology
Applied Biotech Intelligence